SMARCA4 and colorectal carcinoma: Moreover, a reversal experiment confirmed that the knockdown of MUC5AC or MUC2 could inhibit the ability of cell migration and invasion in CRC cells with the overexpression of NICD3 or SMARCA4 (Fig. S4).